Hardman & Co Investor Forum

Confirmed:

Shield Therapeutics Plc

RM Secured Direct Lending Plc

Pantheon International Plc

Hardman & Co are delighted to invite you to our next private investor forum on Tuesday 10th March 2020. Guests presenting on the night include Shield Therapeutics Plc, RM Secured Direct Lending Plc, Pantheon International Plc.

Please note: this event is now accredited and endorsed by the Chartered Institute for Securities & Investment.

The format will comprise of each company presenting for 10 - 15 minutes each, followed by an opportunity for Q&A. The formal part of the evening will be followed by networking over drinks and canapes. If you register to attend, we will send you a four page note on each of the companies approximately one week before.

We believe this will be a highly stimulating evening, which will appeal to a broad spectrum of investors. We hope you can join us.

If you have any questions, please contact Larissa Adams either by email [email protected] or phone 0207 194 7639.

We look forward to welcoming you on 10th March.

Kind regards,

Hardman & Co

----------------------------------------------------------------------------------------------------------------------------

Shield Therapeutics Plc:

Shield Therapeutics is a commercial-stage company delivering specialty products that address patients’ unmet medical needs, with an initial focus on treating iron deficiency (ID) with ferric maltol. Recent news that the FDA had approved this drug for a broad indication opened up a market in the US currently worth over $1bn p.a. – a US partnership deal is expected in 2020. A 2019 trading update showed STX’s performance to be in line with expectations, with £0.6m in sales-related revenue from Norgine’s sales of Feraccru in Europe and £2.3m in milestones. STX’s cash runway extends into 2021, in the absence of a US deal.

RM Secured Direct Lending Plc:

RMDL aims to generate attractive and regular dividends through investment in debt instruments that are backed by real assets, led by exceptional management teams and that usually demonstrate high cashflow visibility. RMDL could be viewed as an alternative to social infrastructure investment companies, with that sector becoming an increasingly important part of RMDL’s portfolio. Compared with such investments, RMDL i) offers a higher dividend yield, ii) carries less downside risk, and iii) has a non-correlated share price. RMDL does not have the same equity upside, but offers investors a different portfolio option.

Pantheon International Plc:

Pantheon International Plc is an investment trust that invests in a diversified portfolio of private equity assets managed by third party managers across the world. PIP is the longest established private equity fund-of-funds on the London Stock Exchange, and has outperformed the FTSE All-Share and MSCI World since its inception in 1987. Pantheon, on average, has generated ca.1.5x the market’s returns since inception in 1987 (11.6% p.a. CAGR in NAV per share), delivered by i) PE-owned businesses outperforming quoted ones, ii) PIP investing in the right PE subsectors, iii) benefits from being in the Pantheon family, and iv) a structured fund.